RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MASI G
Collezione AO Ordine Mauriziano

Items : 5

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial. in ESMO open / ESMO Open. 2025 Feb;10(2):104110. doi: 10.1016/j.esmoop.2024.104110. Epub 2025 Jan 27.

2025
AO Ordine Mauriziano

Piscaglia F; Masi G; Martinelli E; Cabibbo G; Di Maio M; Gasbarrini A; Iavarone M; Antonuzzo L; Mazzaferro V; Ballestrero A; Garufi C; Bergamo F; Celsa C; Marino D; Tovoli F; Ponziani FR; Pressiani T; Astolfi C; Gazzoli GC; Ciardiello F; Daniele B; Rimassa L;

Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. in Frontiers in oncology / Front Oncol. 2023 Aug 7;13:1232476. doi: 10.3389/fonc.2023.1232476. eCollection 2023.

2023
AO Ordine Mauriziano

Lorusso D; Danesi R; Locati LD; Masi G; De Giorgi U; Gadducci A; Pignata S; Sabbatini R; Savarese A; Valabrega G; Zamagni C; Colombo N;

Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Dec;34(8):543-549. doi: 10.1080/1120009X.2022.2036557. Epub 2022 Feb 14.

2022
ASL Biella
AO Ordine Mauriziano

Pellino A; Faloppi L; Scartozzi M; Salani F; Satolli MA; Vivaldi C; Fenocchio E; Frega G; Aglietta M; Aprile G; Masi G; Filippi R; Palloni A; Santini D; Galizia E; Lai E; Lonardi S; Montagnani F; Silvestris N; Pella N; Fornaro L; Leone F; Brandi G; Casadei-Gardini A; Rimini M; Sperti E; Burgio V; Ratti F; Aldrighetti L; et alii...

Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. in Frontiers in oncology / Front Oncol. 2022 Sep 21;12:979519. doi: 10.3389/fonc.2022.979519. eCollection 2022.

2022
AO Ordine Mauriziano

Lorusso D; Danesi R; Locati LD; Masi G; De Giorgi U; Gadducci A; Pignata S; Sabbatini R; Savarese A; Valabrega G; Zamagni C; Colombo N;

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Aug 20:JCO2001225. doi: 10.1200/JCO.20.01225.

2020
AO Ordine Mauriziano

Cremolini C; Antoniotti C; Stein A; Bendell J; Gruenberger T; Rossini D; Masi G; Ongaro E; Hurwitz H; Falcone A; Schmoll HJ; Di Maio M;